CareDx, Inc.

CDNA

CareDx, Inc. (CDNA) is a molecular diagnostics company specializing in transplantation testing and monitoring. It develops and commercializes proprietary diagnostic products to improve graft survival and patient outcomes for organ transplant recipients. The company's offerings include assays for immune system monitoring and early detection of organ rejection, primarily serving the transplant community.

$39.73 -0.45 (-1.12%)
🚫 CareDx, Inc. does not pay dividends

Company News

CareDx Sharpens Focus On Core Testing Services
Benzinga • Vandana Singh • April 16, 2026

CareDx agreed to sell its Lab Products business to EuroBio Scientific for $170 million in cash, allowing the company to focus on its higher-growth Testing Services and Patient and Digital Solutions segments. The company reported strong preliminary Q1 2026 results with 39% year-over-year revenue growth, with Testing Services up 48% and Patient and...

CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026
The Motley Fool • Adé Hennis • February 1, 2026

CareDx CEO John Walter Hanna Jr. sold 19,480 shares on January 21-22, 2026, totaling approximately $412,200 at an average price of $21.16 per share through a pre-planned Rule 10b5-1 trading plan. The sale reduced his direct holdings by 3.16%, leaving him with 597,405 shares. The article notes this shouldn't concern investors, as the company repor...

Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
GlobeNewswire Inc. • N/A • May 22, 2025

Johnson Fistel, a law firm, has initiated an investigation into the board members and executive officers of CareDx, Inc. for potential breaches of fiduciary duties and violations of federal securities laws. The investigation is related to CareDx's issuance of false and misleading public statements regarding its compliance with healthcare laws and...

ALERTA PARA LOS ACCIONISTAS: Morris Kandinov investiga a CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., y Tax Free Fund for Puerto Rico Residents, Inc.; se anima a los accionistas a ponerse en contacto con la firma
GlobeNewswire Inc. • N/A • September 24, 2024

The law firm Morris Kandinov is investigating several companies, including CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., and Tax Free Fund for Puerto Rico Residents, Inc., for potential breaches of fiduciary duties and other legal violations on behalf of shareholders.

SHAREHOLDER ALERT: Morris Kandinov Investigating CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., and Tax Free Fund for Puerto Rico Residents, Inc.; Shareholders are Encouraged to Contact the Firm
GlobeNewswire Inc. • N/A • September 24, 2024

Morris Kandinov, a national law firm, is investigating potential breaches of fiduciary duties and other legal violations by CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., and Tax Free Fund for Puerto Rico Residents, Inc. Shareholders are encouraged to contact the firm to learn more about the...

Related Companies